[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583949":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":32,"locations":37,"responsibleParty":56,"collaborators":24,"id":59,"slug":24,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":62,"acronym":24,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":24,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":24,"overallStatus":39,"whyStopped":24,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Maternal and Child Health Hospital of Hubei Province","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ciprofol group","EXPERIMENTAL","Ciprofol group patients will be given ciprofol during anesthesia induction and maintenance",[13],"Other: Ciprofol group",{"label":15,"type":16,"description":17,"interventionNames":18},"Propofol group","ACTIVE_COMPARATOR","Propofol group patients will be given propofol during anesthesia induction and maintenance",[19],"Other: Propofol group",[21,25],{"type":6,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"In the Ciprofol group,children were given Ciprofol 0.6-0.8 mg\u002Fkg during anesthesia induction,and ciprofol 1.2-2 mg·kg-¹·h-¹for anesthesia maintenance.Throughout the entire process, we continuously monitor vital signs and IoC1\u002FIoC2.",[9],null,{"type":6,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"In the Propofol group,children were given Propofol 2.5-3.5 mg\u002Fkg during anesthesia induction,and propofol 6-10 mg·kg-¹·h-¹for anesthesia maintenance.Throughout the entire process, we continuously monitor vital signs and IoC1\u002FIoC2.",[15],[29],{"name":30,"affiliation":5,"role":31},"Na Li, MD","PRINCIPAL_INVESTIGATOR",[33],{"name":30,"role":34,"phone":35,"phoneExt":24,"email":36},"CONTACT","Telephone: Telephone:+86276349","Email:lina@hbfy.com",[38],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Wuhan","Hubei","430000","China","CN",{"type":46,"coordinates":47},"Point",[48,49],114.26667,30.58333,{"lat":49,"lon":48},[52],{"name":53,"role":34,"phone":54,"phoneExt":24,"email":55},"Na Li,","+862763490107","lina@hbfy.com",{"type":31,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Li Na","Deputy chief physician Investigator Affiliation Maternal and Child Health Hospital of Hubei Province","100583949",false,"NCT06882980","Comparison of Ciprofol and Propofol Under IoC1 and IoC2 Monitoring for Adenotonsillectomy","Inclusion Criteria:\n\n* ASA I\u002FII, age 3-11 years, weight 13-50 kg.\n\nEndoscopic T\\&A or adenoidectomy.\n\nExclusion Criteria:\n\n* Recent upper respiratory infection.\n\nDifficult airway, organ dysfunction, developmental\u002Fpsychiatric disorders.\n\nDrug allergies.",true,"ALL","3 Years","11 Years",{"count":69,"type":70},236,"ESTIMATED","INTERVENTIONAL",[73],"NA","The goal of this clinical trial is to compare the Ciprofol and Propofol Under IoC1 and IoC2 Monitoring for Adenotonsillectomy Participants will be randomly allocated to two groups: Ciprofol group (Group C) and Propofol group (Group P). For those in Group C: they will be given ciprofol during anesthesia induction and maintenance .For those in Group P: they will be pgiven ciprofol during anesthesia induction and maintenanc This study evaluates ciprofol versus propofol under IoC1\u002FIoC2 guidance in pediatric T\\&A, providing evidence for ciprofol's efficacy and safety in pediatric anesthesia.",[76,77,78],"Adenotonsillectomy","Propofol","Ciprofol","2025-06-11",{"date":81,"type":82},"2025-06-12","ACTUAL",{"date":84,"type":82},"2025-02-22",{"date":86,"type":70},"2025-11-22",{"name":5,"class":6},1]